A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent Neuroblastoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01109238 |
|
Recruitment Status :
Completed
First Posted : April 23, 2010
Last Update Posted : April 28, 2022
|
Sponsor:
Wake Forest University Health Sciences
Collaborator:
Van Andel Research Institute
Information provided by (Responsible Party):
Wake Forest University Health Sciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | July 2010 |
| Actual Study Completion Date : | July 2010 |